Drug Trial Radar · NCT03852654
18F-DCFPyL PET-CT Scan and Prostate Cancer
Last checked: Nov 19, 2026Latest source record: Feb 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
170
Planned (sponsor's estimate)
Start
Jul 22, 2018
Primary completion
Dec 30, 2019
Study completion Jun 30, 2020
Sponsor
- Lead sponsor
- Lida JafariFederal agency
- Sponsor type
- Federal agency
- Collaborators
- University of California, Los Angeles
- First posted
- Feb 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: The primary objective of this study is to assess the efficacy of 18F-DCFPyL PET-CT for initial staging of prostate cancer in Veterans compared to conventional imaging (99mTc-MDP bone scan and Diagnostic CT or MRI). The primary clinical endpoint of our study is the percent of Veterans with prostate cancer in which the 18F-DCFPyL PET-CT identifies M1 disease at initial staging. Secondary Objectives: Frequency of the change in primary treatment plan after initial staging.
Conditions
- Prostate Cancer Adenocarcinoma
Interventions
18F-DCFPyLDrug
Subjects with biopsy proven prostate cancer, no prior local therapy, and: PSA ≥ 10 ng/dl, or Gleason Sum ≥ 4+3, or clinical stage ≥cT2c Staging by 99mTc-MDP or NaF PET bone scan, and Diagnostic CT (pelvis) or MRI will undergo 18F DCFPyL PET CT scan.
Primary outcomes
What the sponsor says the trial is designed to measure.
- the percent of Veterans with prostate cancer in which the 18F-DCFPyL PET-CT identifies M1 disease at initial stagingTime frame: 120 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
VA Greater Los Angeles
Los Angeles, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.